Omega Therapeutics Statistics
Total Valuation
OMGAQ has a market cap or net worth of 885,859. The enterprise value is 98.64 million.
| Market Cap | 885,859 |
| Enterprise Value | 98.64M |
Important Dates
The last earnings date was Friday, February 28, 2025.
| Earnings Date | Feb 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OMGAQ has 55.37 million shares outstanding. The number of shares has increased by 5.61% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 55.37M |
| Shares Change (YoY) | +5.61% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 1.62% |
| Owned by Institutions (%) | 15.89% |
| Float | 21.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.11 |
| PB Ratio | 0.08 |
| P/TBV Ratio | 0.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.35 |
| EV / Sales | 12.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.71 |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 11.10.
| Current Ratio | 1.61 |
| Quick Ratio | 1.30 |
| Debt / Equity | 11.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.22 |
| Interest Coverage | -41.17 |
Financial Efficiency
Return on equity (ROE) is -166.90% and return on invested capital (ROIC) is -26.72%.
| Return on Equity (ROE) | -166.90% |
| Return on Assets (ROA) | -25.01% |
| Return on Invested Capital (ROIC) | -26.72% |
| Return on Capital Employed (ROCE) | -57.68% |
| Revenue Per Employee | 86,117 |
| Profits Per Employee | -777,574 |
| Employee Count | 94 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 1.84 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 1,202,163 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.06 |
Income Statement
In the last 12 months, OMGAQ had revenue of 8.10 million and -73.09 million in losses. Loss per share was -1.33.
| Revenue | 8.10M |
| Gross Profit | -34.50M |
| Operating Income | -74.15M |
| Pretax Income | -73.09M |
| Net Income | -73.09M |
| EBITDA | -72.41M |
| EBIT | -74.15M |
| Loss Per Share | -1.33 |
Balance Sheet
The company has 30.38 million in cash and 128.13 million in debt, giving a net cash position of -97.76 million or -1.77 per share.
| Cash & Cash Equivalents | 30.38M |
| Total Debt | 128.13M |
| Net Cash | -97.76M |
| Net Cash Per Share | -1.77 |
| Equity (Book Value) | 11.54M |
| Book Value Per Share | 0.21 |
| Working Capital | 14.78M |
Cash Flow
In the last 12 months, operating cash flow was -55.58 million and capital expenditures -2.06 million, giving a free cash flow of -57.64 million.
| Operating Cash Flow | -55.58M |
| Capital Expenditures | -2.06M |
| Free Cash Flow | -57.64M |
| FCF Per Share | -1.04 |
Margins
| Gross Margin | n/a |
| Operating Margin | -916.00% |
| Pretax Margin | -902.93% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OMGAQ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.61% |
| Shareholder Yield | -5.61% |
| Earnings Yield | -8,250.97% |
| FCF Yield | -6,506.68% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OMGAQ has an Altman Z-Score of -4.41. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.41 |
| Piotroski F-Score | n/a |